Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Fox

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2025
Blocking C-terminal processing of KRAS4b via a direct covalent attack on the CaaX-box cysteineAnna E Maciag, Yue Yang, Alok K Sharma, et al.
Histopathology|March 31, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programmeHeather Thorne, Lisa Devereux, Jason Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 20, 2019
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion studyHélène Dano, Serdar Altinay, Laurent Arnould, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2021
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA studyMieke R Van Bockstal, Aline François, Serdar Altinay, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Breast Cancer Research : BCR|February 10, 2016
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, et al.
Breast Cancer Research : BCR|November 8, 2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A Ligon, R Taylor Sundby, Mary F Wedekind, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2025
Blocking C-terminal processing of KRAS4b via a direct covalent attack on the CaaX-box cysteineAnna E Maciag, Yue Yang, Alok K Sharma, et al.
Histopathology|March 31, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programmeHeather Thorne, Lisa Devereux, Jason Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 20, 2019
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion studyHélène Dano, Serdar Altinay, Laurent Arnould, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2021
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA studyMieke R Van Bockstal, Aline François, Serdar Altinay, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Breast Cancer Research : BCR|February 10, 2016
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, et al.
Breast Cancer Research : BCR|November 8, 2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan, Fergus J Couch, Daniel Barrowdale, et al.
Pageof 12